Lance Steward is currently the Head of Toxin Innovation in Biological Research and R&D at Allergan Aesthetics, AbbVie, where they have been since 2021. Previously, they served as the Executive Director of Biological Research at AbbVie from 2020 to 2022 and held the same position at Allergan from 2017 to 2020. Lance completed a NIH Post-Doctoral Fellowship at the University of Utah from 1996 to 1999, following their Ph.D. in Chemistry from UC Irvine, which they earned in 1996, and a B.S. in Chemistry from the University of Illinois Urbana-Champaign in 1989.
This person is not in any teams
This person is not in any offices